COSM - Why Is Nutraceuticals Player Cosmos Health Stock Trading Higher Today? | Benzinga
Cosmos Health Inc (NASDAQ: COSM) announced its inaugural 2026 revenue and EBITDA guidance.
The company forecasts over $180 million in gross annual revenue, with EBITDA in excess of $20 million.
Greg Siokas, CEO of Cosmos Health, stated: "We are pleased to announce guidance based on our long-term outlook ...